Journal
PEDIATRIC NEPHROLOGY
Volume 20, Issue 7, Pages 967-971Publisher
SPRINGER
DOI: 10.1007/s00467-005-1884-y
Keywords
peritoneal dialysis; phosphorus; compliance; renal diet; phosphate binders
Categories
Ask authors/readers for more resources
Hyperphosphatemia has been associated with the development of secondary hyperparathyroidism, renal osteodystrophy, cardiovascular calcification and increased risk of death. Using a one group, pretest-posttest study design, we sought to evaluate changes in serum phosphorus, calcium, parathyroid hormone and subject knowledge in response to a 3-month educational intervention. Mean serum phosphorus levels did not differ significantly between the three evaluation periods: pretreatment ( 5.69 mg/dl), treatment ( 5.84 mg/dl) and post-treatment (6.17 mg/dl). Mean serum calcium, calcium-phosphorus product and PTH values also did not differ significantly between the treatment periods. We observed no difference between the subject test scores between the two testing periods. Calcium-phosphorus product, serum phosphorus and PTH values on average, despite the education program, remained outside the K/DOQI target guidelines 44, 56 and 81% of the time, respectively. The results of this study suggest that an aggressive 3-month patient education program targeting dietary phosphorus knowledge, phosphate binder name and dosing, and knowledge of medical consequences associated with noncompliance had no effect on the serum phosphorus, calcium, PTH or phosphate binder need.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available